Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2020-07-04 Board/Management Inform…
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges and regulatory bodies about the resignation of an Independent Director, Mrs. Neha A Thakore, from the company Lyka Labs Limited. It references compliance with SEBI Listing Obligations and Disclosures Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosure of events or information. The content includes the resignation letter and details about the cessation date and reason for resignation. There are no financial statements, earnings data, or report publications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2020-07-04 English
We wish to inform you that Mrs. Neha A Thakore has resigned as an Independent Director of the Company vide her letter dated 03rd July, 2020 received through email Please find the disclosures ....
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of an Independent Director, Mrs. Neha A Thakore, from the company Lyka Labs Limited. It references compliance with SEBI Regulation 30 concerning disclosure of changes in directors. The content includes the resignation letter and details about the cessation date and reason. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a change in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length is short and focused solely on this management change, confirming the classification.
2020-07-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is very short (544 characters) and contains addresses to stock exchanges with script codes, but no substantive financial data, analysis, or detailed report content. It appears to be a brief communication or notice rather than a full report. There is no indication of financial statements, management discussion, or detailed disclosures. Given the brevity and nature, it is likely a Regulatory Filing (RNS) as a general announcement or compliance document without detailed report content.
2020-06-29 English
This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider ....
Regulatory Filings
2020-06-29 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (525 characters) and mostly consists of omitted images and address headers for stock exchanges. There is no substantive content, financial data, or detailed report information. It appears to be a brief notice or announcement related to stock exchange listings or filings, but no actual report or detailed filing is present. Given the brevity and lack of report content, this fits the pattern of a Regulatory Filing (RNS), which is a fallback category for miscellaneous short regulatory announcements that do not fit other categories.
2020-06-15 English
Pursuant to SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 144 dated 26th November, 2018, regarding fund raising by issuance of Debt Securities by Large Entity and disclosure and compliance ....
Regulatory Filings
2020-06-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.